To that end, we used a pharmacological approach (P2Y2 is suramin-sensitive) and P2Y2-knowdown of Schwannoma cells, which suggested a predominant role of P2Y2 receptors in this migratory effect. The gene discussed is P2RY2; the disease is schwannoma.